10x Genomics to Present at the 44th Annual J.P. Morgan Healthcare Conference
10x Genomics (Nasdaq: TXG) announced that members of its management will present at the 44th Annual J.P.
Rhea-AI Summary
10x Genomics (Nasdaq: TXG) announced that members of its management will present at the 44th Annual J.P. Morgan Healthcare Conference on Monday, January 12, 2026 at 8:15 a.m. Pacific Time.
Investors and interested parties can watch a live webcast of the fireside chat via the company's Investors website at https://investors.10xgenomics.com/. The webcast will be archived and available for replay for at least 30 days after the event.
Positive
- None.
Negative
- None.
Details
News Market Reaction – TXG
On Dec 30, the first trading day after this news, TXG closed 0.87% above the previous close.
Data tracked by StockTitan Argus for the Dec 30 session.
Key Figures
- Conference date
- January 12, 2026
- J.P. Morgan Healthcare Conference presentation date
- Start time
- 8:15 a.m. Pacific Time
- Scheduled time for conference fireside chat
- Webcast replay period
- 30 days
- Archived webcast availability after the event
Historical Context
-
Launch of ASTRA alliance to build pan-cancer spatial atlas using Xenium.
-
Management fireside chat at Wolfe Research Healthcare Conference 2025.
-
Q3 2025 results with $149M revenue and narrowed operating and net losses.
-
Next-generation Chromium Flex launch to scale single cell research throughput.
-
Collaboration with Anthropic to integrate tools into Claude for Life Sciences.
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Key Terms
spatial biology medical
AI-generated analysis. How Rhea-AI works. Not financial advice.
Interested parties may access a live webcast of the fireside chat on the "Investors" section of the company's website at: https://investors.10xgenomics.com/. The webcast will be archived and available for replay for at least 30 days after the event.
About 10x Genomics
10x Genomics is a life science technology company building products to accelerate the mastery of biology and advance human health. Our integrated research solutions include instruments, consumables and software for single cell and spatial biology, which help academic and translational researchers and biopharmaceutical companies understand biological systems at a resolution and scale that matches the complexity of biology. Our products are behind breakthroughs in oncology, immunology, neuroscience and more, fueling powerful discoveries that are transforming the world's understanding of health and disease. To learn more, visit 10xgenomics.com or connect with us on LinkedIn, X, Facebook, Bluesky or YouTube.
Disclosure Information
10x Genomics uses filings with the Securities and Exchange Commission, our website (www.10xgenomics.com), press releases, public conference calls, public webcasts and our social media accounts as means of disclosing material non-public information and for complying with our disclosure obligations under Regulation FD.
Contacts
Investors: investors@10xgenomics.com
Media: media@10xgenomics.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/10x-genomics-to-present-at-the-44th-annual-jp-morgan-healthcare-conference-302650016.html
SOURCE 10x Genomics, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.